Compare GH & GGG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GH | GGG |
|---|---|---|
| Founded | 2011 | 1926 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Fluid Controls |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 13.8B |
| IPO Year | 2018 | N/A |
| Metric | GH | GGG |
|---|---|---|
| Price | $110.09 | $85.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 21 | 2 |
| Target Price | ★ $99.48 | $94.00 |
| AVG Volume (30 Days) | ★ 1.9M | 736.8K |
| Earning Date | 02-19-2026 | 01-26-2026 |
| Dividend Yield | N/A | ★ 1.39% |
| EPS Growth | N/A | ★ 3.48 |
| EPS | N/A | ★ 2.93 |
| Revenue | $902,569,000.00 | ★ $2,192,120,000.00 |
| Revenue This Year | $35.00 | $6.75 |
| Revenue Next Year | $26.80 | $4.83 |
| P/E Ratio | ★ N/A | $29.09 |
| Revenue Growth | ★ 30.38 | 2.85 |
| 52 Week Low | $34.80 | $72.06 |
| 52 Week High | $113.91 | $89.67 |
| Indicator | GH | GGG |
|---|---|---|
| Relative Strength Index (RSI) | 63.59 | 62.50 |
| Support Level | $106.42 | $82.54 |
| Resistance Level | $113.91 | $85.03 |
| Average True Range (ATR) | 3.97 | 1.46 |
| MACD | 0.63 | 0.21 |
| Stochastic Oscillator | 77.16 | 92.10 |
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Graco manufactures equipment used for managing fluids, coatings, and adhesives, specializing in difficult-to-handle materials. Graco's business is organized into three segments: industrial, process, and contractor. The Minnesota-based firm serves a wide range of end markets, including industrial, automotive, and construction, and its broad array of products include pumps, valves, meters, sprayers, and equipment used to apply coatings, sealants, and adhesives. The firm generated roughly $2.1 billion in sales in 2024.